Sign in

NCT05927623Completed

Multifaceted Intervention Using Telehealth to Reduce the Risk of Falls and Fractures in Older Men

Multifaceted Intervention Using Telehealth to Reduce the Risk of Falls and Fractures in Older Men (MisterFit): A Pilot Study

Source: ClinicalTrials.gov · Last updated 20 Apr 2026

Brief summary (registry, in English)

Men sustain over one-third of osteoporosis-related fractures worldwide. The burden of osteoporotic fractures in older men is substantial, and men suffer significantly worse fracture-related outcomes than women. Following a fracture, men sustain greater rates of subsequent fractures, loss of autonomy, and mortality than women and the imminent risk of re-fracture is several times higher in men than in women. Functional mobility, known to predict falls and fractures, is also notably worse in men following a fracture. In the fiscal year 2007-08, the overall annual costs of osteoporosis in Canadian men was evaluated to be $910 million. Osteoporosis is primarily considered a disease of older women, and men are remarkably under-evaluated and under-treated for it. Recognition of sex and gender influences on skeletal health in men has been very slow; akin to the gap in cardiovascular diseases, where women are far less likely to receive guideline-recommended investigations and treatment. Over 85% of Canadian men who suffer from fragility fractures do not receive osteoporosis screening and/or treatment strategies. The existence of this care gap in men underscores our current struggle to overcome important barriers including: 1) men's lack of awareness of the critical impact of osteoporosis and fractures on several aspects of their lives, and of the benefits of treatment; and 2) the absence of comprehensive and accessible treatments tailored to men. Informed by the Knowledge-to-Action framework, we aim to address these barriers by adapting interventions with proven efficacy to engage men at high fracture risk in health behaviour change. The current protocol is for a pilot RCT to determine the feasibility of recruitment and retention, adherence to, and acceptability of the virtually-delivered fracture prevention intervention only. Our long-term goal is to conduct a large pragmatic randomized controlled trial (RCT) to address the research question: In older adults at high risk for fractures who self-identify as men, does anti-osteoporosis pharmacotherapy in conjunction with a virtually-delivered intervention that includes a gender-tailored strength training and balance based exercise program and nutritional counselling, improve functional mobility compared to anti-osteoporosis pharmacotherapy in conjunction with an attention control intervention.

Status (registry)
Completed
Study type
Interventional
Enrollment
45 (actual)
First submitted
21 Jun 2023
Start date
7 Feb 2023
Primary completion date
31 Mar 2026
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Diseases
Osteoporosis
NCT number
NCT05927623

What you commit to

  • Study type: Interventional
  • Participants enrolled: 45
  • From 7 Feb 2023 to the primary completion date, 31 Mar 2026
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Uncontrolled medical comorbidity including but not limited to congestive heart failure exacerbation in the last 12 months or COPD exacerbation in the last 3 months
  • Unable to perform basic activities of daily living or severe cognitive impairment or terminal illness

Other

  • Inability to communicate in English or French;
  • No access to a mobile device, tablet, or computer with a camera;
  • Clinical or symptomatic spine fracture in the last 4 months, or a lower/upper limb fracture in the last 2 months;
  • Currently doing or planning to start doing either: A) Resistance training exercises with a self-rated intensity of very hard (e.g., rated ≥ 8 on a scale from 0-10) for two or more times a week OR B) Exercises to improve balance for two or more times a week
  • Presence of absolute exercise contraindications unless physician approval is obtained if contraindications are present

Criteria the registry did not label

  • Community-dwelling individuals ≥ 60 years who self-identify as men will be considered eligible if their risk for fracture is evaluated to be high, defined by the presence of one of the following inclusion criteria:
  • Individuals on a Heath Canada-approved anti-osteoporosis medication (oral or intravenous bisphosphonate, denosumab, teriparatide, or romozosumab) to reduce fracture risk
  • Prior hip or clinically diagnosed vertebral fracture or prior multiple fragility fractures since age 40
  • Fracture at any skeletal site (excluding skull, hands, and feet) within the previous 2 years
  • Ten-year probability of major osteoporotic fracture of ≥20% using the FRAX tool
  • BMD T-score of ≤ -2.0 (performed as part of usual clinical care) WITH either the presence of one or more moderate or severe vertebral fractures on spine radiography OR the presence of ≥1 comorbidities (Diabetes Type I or Type II if on treatment, Parkinson's disease, congestive heart failure, chronic obstructive pulmonary disease (COPD) with previous systemic corticosteroid exposure, prostate cancer with current or prior recent (≤ 2 years) use of hormonal therapy) OR ≥ 2 falls in the previous year
  • BMD T-score of ≤ -2.5 and ≥ 70 years of age

Age in the registry: 60 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Of Calgary
Coordinator of this site? Confirm its status
CalgaryCanadaUnknown status
McMaster University
Coordinator of this site? Confirm its status
HamiltonCanadaUnknown status
McGill University Health Centre
Coordinator of this site? Confirm its status
MontrealCanadaUnknown status
Centre hospitalier universitaire de Québec
Coordinator of this site? Confirm its status
QuébecCanadaUnknown status
University Health Network
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.